Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement

优化俄亥俄州社区 (OHiO) 的治疗 - 健康公平补充

基本信息

  • 批准号:
    10890393
  • 负责人:
  • 金额:
    $ 79.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-15 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract This supplement aims to explore the impact of the infusion of health equity principles on overdose prevention strategies during implementation of the Communities That Heal (CTH) intervention as part of the HEALing Communities Study (HCS). The HCS is a multi-site, parallel arm, cluster randomized, wait-list controlled trial evaluating the impact of the CTH intervention compared with usual care in wait-list communities, on overdose deaths. The overall goal of the HCS is to reduce opioid overdose deaths by 40% in 67 HCS communities across four states. Communities form coalitions to make shared decisions about what overdose prevention strategies to implement and how best to implement them, particularly strategies that promote Overdose Prevention Education and Naloxone Distribution (OEND) and Medications for Opioid Use Disorder (MOUD). While it is known that minoritized communities (whether due to race, ethnicity, gender, or LGBTQIA+ status) have less and poorer access to treatment for Opioid Use Disorder (OUD) and associated disparities in outcomes, at its outset, HCS did not explicitly aim to reduce disparities or measure the effect of centering equity on overdose prevention. This approach changed in 2020 with acute awareness of the racial and ethnic disparities within the COVID epidemic and the racial awakening in response to the George Floyd killing. This supplement will leverage the existing infrastructure and study staff of its parent study to analyze survey and other qualitative data already collected. The primary data sources will include surveys of coalition members, completed at four time points during the study period; the Opioid-Overdose Reduction Continuum of Care Approach Tracker (ORCCAT), completed monthly by study staff, that includes overdose prevention information by strategy, sector, venue, population served, coalition approval date, implementation plan developed, date started, number of partners/practices associated with strategy, and mode of delivery; and REACH data, completed by study staff monthly once each strategy is implemented that includes information on number of persons reached and demographics of those reached (e.g., race, ethnicity, sex, age). Data analysis will include both quantitative analysis examining associations between survey answers regarding health equity topics and incorporation of equity into strategies, as well as qualitative analysis examining how coalitions discussed and prioritized equity topics. This study will be guided by the parent study’s PRISM/RE-AIM(S) conceptual framework with a novel health equity lens to examine how diversifying coalitions and infusing opioid overdose prevention strategies with health equity principles may help reach minoritized communities and how these contextual factors and processes may interact to promote or impede health equity. Results from this study may be used to inform policies, strategies, and practices for incorporating health equity principles when implementing overdose prevention strategies.
项目总结/摘要 这一补充旨在探讨影响的输液健康公平原则对过量预防 在实施社区愈合(CTH)干预作为治疗的一部分, 社区研究(HCS)。HCS是一项多中心、平行组、随机分组、等待列表对照试验 评估CTH干预与等待名单社区的常规护理相比对过量的影响 死亡HCS的总体目标是在67个HCS社区将阿片类药物过量死亡减少40% 横跨四个州社区组成联盟,共同决定如何预防过量用药 实施战略以及如何最好地实施这些战略,特别是促进过量用药的战略 预防教育和纳洛酮分配(OEND)和阿片类药物使用障碍(MOUD)。 虽然众所周知,少数群体(无论是由于种族,民族,性别,或LGBTQIA+状态) 获得阿片类药物使用障碍(OUD)治疗的机会较少和较差, 从一开始,HCS并没有明确的目标是减少差距或衡量集中的效果, 预防过量用药的公平性。这种做法在2020年发生了变化,人们对种族和民族的认识深刻 新冠疫情内部的差异以及对乔治弗洛伊德被杀事件的种族觉醒。这 补充将利用其母研究的现有基础设施和研究人员来分析调查, 已收集的其他定性数据。主要数据来源将包括对联盟成员的调查, 在研究期间的四个时间点完成;阿片类药物过量减少连续护理 方法跟踪器(ORCCAT),由研究工作人员每月完成,包括药物过量预防信息 按战略、部门、地点、服务人口、联盟批准日期、制定的实施计划、日期 开始,与战略相关的合作伙伴/实践的数量,以及交付模式;以及REACH数据, 一旦实施每项策略,研究工作人员每月填写一次,其中包括 所到达的人和所到达的人的人口统计(例如,种族、民族、性别、年龄)。数据分析将包括 这两种定量分析都检查了关于健康公平主题的调查答案之间的关联, 将公平纳入战略,并进行定性分析,审查联盟如何讨论和 优先考虑公平问题。本研究将遵循母研究的PRISM/RE-AIM(S)概念 一个新的健康公平透镜框架,以研究如何多样化联盟和注入阿片类药物过量 具有健康公平原则的预防战略可能有助于覆盖少数群体社区, 背景因素和过程可能相互作用,促进或阻碍卫生公平。本研究结果可 用于为纳入健康公平原则的政策、战略和实践提供信息, 实施过量用药预防策略。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Community Coalitions' Perspectives on Engaging with Hospitals in Ohio to Address the Opioid Crisis.
社区联盟对与俄亥俄州医院合作解决阿片类药物危机的看法。
  • DOI:
    10.1089/pop.2022.0174
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Walker,DanielM;Shiu-Yee,Karen;Chen,Sadie;DePuccio,MatthewJ;Jackson,RebeccaD;McAlearney,AnnScheck
  • 通讯作者:
    McAlearney,AnnScheck
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bridget J Freisthler其他文献

Bridget J Freisthler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bridget J Freisthler', 18)}}的其他基金

Changes in Alcohol Use and Harsh Parenting during COVID-19
COVID-19 期间酒精使用的变化和严厉的养育方式
  • 批准号:
    10393310
  • 财政年份:
    2021
  • 资助金额:
    $ 79.98万
  • 项目类别:
Changes in Alcohol Use and Harsh Parenting during COVID-19
COVID-19 期间酒精使用的变化和严厉的养育方式
  • 批准号:
    10491191
  • 财政年份:
    2021
  • 资助金额:
    $ 79.98万
  • 项目类别:
Optimizing HEALing in Ohio Communities (OHiO)
优化俄亥俄州社区的治疗 (OHiO)
  • 批准号:
    10388335
  • 财政年份:
    2019
  • 资助金额:
    $ 79.98万
  • 项目类别:
Assessing Changes in Child Maltreatment due to the Sacramento Neighborhood Alcohol Prevention Project
评估萨克拉门托社区酒精预防项目导致的儿童虐待变化
  • 批准号:
    9978664
  • 财政年份:
    2018
  • 资助金额:
    $ 79.98万
  • 项目类别:
Evaluating the Geography of Medical Cannabis Facilities on Crime, Price and Use
评估医用大麻设施的地理分布、犯罪、价格和使用情况
  • 批准号:
    8661148
  • 财政年份:
    2011
  • 资助金额:
    $ 79.98万
  • 项目类别:
Evaluating the Geography of Medical Cannabis Facilities on Crime, Price and Use
评估医用大麻设施的地理分布、犯罪、价格和使用情况
  • 批准号:
    8473841
  • 财政年份:
    2011
  • 资助金额:
    $ 79.98万
  • 项目类别:
Evaluating the Geography of Medical Cannabis Facilities on Crime, Price and Use
评估医用大麻设施的地理分布、犯罪、价格和使用情况
  • 批准号:
    8331437
  • 财政年份:
    2011
  • 资助金额:
    $ 79.98万
  • 项目类别:
Evaluating the Geography of Medical Cannabis Facilities on Crime, Price and Use
评估医用大麻设施的地理分布、犯罪、价格和使用情况
  • 批准号:
    8230832
  • 财政年份:
    2011
  • 资助金额:
    $ 79.98万
  • 项目类别:
Alcohol Availability, Alcohol Use and Child Maltreatment
酒精供应、酒精使用和虐待儿童
  • 批准号:
    7046851
  • 财政年份:
    2005
  • 资助金额:
    $ 79.98万
  • 项目类别:
Alcohol Availability, Alcohol Use and Child Maltreatment
酒精供应、酒精使用和虐待儿童
  • 批准号:
    6927517
  • 财政年份:
    2005
  • 资助金额:
    $ 79.98万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了